Author Archives: admin

Kraig Biocraft Laboratories subsidiary, Spydasilk Enterprises, files for registration of multiple Spider Silk brand trademarks

Kings Group, Kraig’s joint venture partner, leads branding, with unique trademarks centered on spider silk

ANN ARBOR, Mich., – April 22, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that Spydasilk Enterprises Pte. Ltd. (“Spydasilk Enterprises”), the Company’s Singapore based joint venture, with M the Movement and Kings Golden Harvest Pte Ltd (collectively, “Kings Group”), has applied for its first four Spydasilk brand trademarks with the US Patent and Trademark office.

These first four trademarks include brand and product specific marking that Spydasilk Enterprises will use in the branding and marketing of its yarns, textiles, and finished garments.

“Our goal was to design the Spydasilk trademarks to be clean, distinctive, and powerful, able to stand alone or work in collaboration with co-branding opportunities with potential product partners.  I think that our design team delivered on all four of these criteria, creating a memorable brand with the unique inspired design,” said Walter Wee, CIO of Kings Group.

In addition to Spydasilk Enterprises developing a premium apparel, based on Kraig Labs’ spider silk technologies, Kraig Labs and Kings Group are simultaneously building other spider silk sales markets outside of apparel and textiles. With that in mind, the companies are working quickly to build Spydasilk Enterprises’ down channel distribution network.  These additional markets are expected to further expand the previously announced exclusive purchase and sales agreement, valued at up to US$40 million.

“SpydaSilk is obviously a unique enterprise, so we wanted to create trademarks that highlight the technology at the center of the brand. These trademarks provide distinctive styling that will help our customers easily identify Spydasilk’s product and the performance driven technologies at the heart of their design,” said Kim Thompson, Kraig Labs’ founder and CEO.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

About Kings Group and M the Movement

Kings Group is headquartered in Singapore and established regional offices with multiple assets in Indonesia and Vietnam. Kings Group envisions itself to be a forerunner in International Marketing and Trading; bridging domestic businesses and projecting their products internationally.

For further information, please visit www.kings.com.sg

M the Movement is Kings Group’s premiere eco-friendly luxury streetwear line. Internationally recognized and loved by celebrities globally.

For more information, please visit www.mthemovement.com

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company, is a developer of genetically engineered spider silk based fiber technologies.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC

(720) 288-8495

ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Announces That Monster Silk(TM) is Stronger Than Steel

Company Confirms Some of Monster Silk’s Extraordinary Qualities

LANSING, Mich., Sept. 23, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that the Company’s Monster Silk(TM) recombinant spider silk fibers are stronger than the comparable weight of traditional structural steel.

“We’ve long believed that Monster Silk(TM) tensile strength is stronger than steel, but it’s a bonus to be able to quantify and confirm some of its properties for potential commercialization partners,” said Company founder and CEO, Kim K. Thompson.

“Since the Company is producing fibers that have never been produced before, we’ve decided that we will expand our ability to ascertain these results. Therefore, we are investing in testing and measurement equipment that will help us to accelerate the testing of our fibers’ unique qualities in a more efficient manner. We believe that this will advance our ability to communicate intelligently with our potential commercialization partners, improve the effectiveness in the laboratory, and greatly reduce the commercialization timeline for future products that we plan on bringing online.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contact:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Announces Highly Favorable Testing Results for Its Big Red Spider Silk Fiber

Initial Test Results Indicate That Big Red is Even Stronger Than Monster Silk(R)

LANSING, Mich., Sept 10, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that the Company’s initial testing of its recombinant spider silk, Big Red, indicate that the Company’s new recombinant fiber is stronger than Monster Silk(R). The testing indicates that Big Red’s strength, as measured by the ultimate load it can withstand before breaking, is approaching that of natural spider silk.

“These initial testing results appear to confirm the effectiveness of our design approach with Big Red,” said Company founder and CEO, Kim K. Thompson. “Big Red was designed to be even stronger than our breakthrough product, Monster Silk(R),” continued Thompson. “If the follow on testing confirms these results, Big Red will be a significant breakthrough for our Company and for material science.”

“So far, Big Red has met or exceeded our expectations and design parameters. Our plan is for Big Red to follow Monster Silk(R) in our commercialization ramp up.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contact:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Announces Monster Silk(TM) Production at Quantities Necessary for Producing Textile Prototypes

Company to Increase Scale of Its Recombinant Spider Silk Production

LANSING, Mich., August 19, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that the Company’s pilot production program has successfully produced a sufficient quantity of Monster Silk(TM) cocoons to allow the Company to make the first Monster Silk(TM) textile prototypes.

The cocoons still need to be reeled and processed into yarn before the first prototype and sample textiles can be produced. The announcement puts the Company firmly ahead of its most recent textile production schedule. The first textiles are slated for mechanical testing of the properties of recombinant spider silk in various textile knits and/or weaves.

The Company also announced today a change in its production schedule and scale of operations for its initial commercial production program. “The timing of cocoon production from the pilot program worked out well, because we were getting indications from the field that the weather developing in August was not ideal for the mulberry production needed for our commercial launch,” said Company founder and CEO, Kim K. Thompson. “We are going to take advantage of the fact that with this supply of cocoons we have bought ourselves some breathing room. The Company plans to delay the launch of commercial production until sometime in September. We can now do this with no expected impact on our schedule to produce new textiles. By moving the production launch to September we may also be in a position to increase the scale of the initial commercial production by a factor of two or more. The Laboratory is taking full advantage of the time by working on egg production in order to increase the scale of the commercial launch.”

“The pilot production program was the first time that we raised Monster Silk(TM) silkworms in real world conditions,” continued Thompson. “The success of that program has enabled us to prepare for the creation of recombinant spider silk textiles and to increase the scale of our pending launch of spider silk production on a commercial scale.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contact:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Launches New Website

New Website Intended to Communicate the Company’s Vision and Technology

LANSING, Mich., July 22, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced the launch of its entirely new website, www.kraiglabs.com.

“Although we’ve worked with cutting-edge biotech companies in the past, our whole team was fascinated by the incredible things Kraig Biocraft is achieving in the labs,” commented Jonathan Keim, owner of GPGSolutions. “We truly enjoyed working with the Company and being a part of its exciting story.”

“As we move toward the commercialization of recombinant spider silks, it is important that we build our band and our image,” said Company CEO and founder, Kim K Thompson. “With Jonathan’s help, we built a website from the ground up, to better highlight the Company’s high-tech foundations and enhance our public image. The new and improved website is also part of our plan to improve communication with prospective partners, customers and our shareholders. We hired GPGSolutions’ because of their stellar reputation and their enthusiasm for the project. Their creativity, responsiveness and technical ability worked to produce a platform that better represents our vision and promotes our brand.”

Shareholders and interested persons who have not already done so, are invited to subscribe to the Company’s email updates in advance of the launch of that program. The sign in button can be found at the bottom of the Investors page of the Company website.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contact:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories to Launch Commercial Production of Monster Silk(TM)

LANSING, Mich., July 15, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, today announced that it is scheduled to start commercial production of Monster Silk™.

The first phase, scheduled to begin within the next three weeks, will be focused on establishing commercial scale production capacity. “We have been laying the ground work for commercial production over the last six months with our pilot production program,” said Company CEO and founder, Kim K Thompson. “We have moved cautiously and prudently in testing our methods and procedures. It’s now time to convert the pilot program to commercial production.”

The launch of commercial production follows on the heels of the Company’s pilot production program which has been running since January.

“The successful scale-up to commercial production is a significant milestone for any company,” continued Thompson, “and, considering the importance we place on Monster Silk™, I have to agree that this is a momentous step for Kraig. It is especially exciting because we are creating what we believe will be the world’s first commercial scale production of recombinant spider silk.”

While the Company is creating this production capacity, it is in discussions with one or more other countries about further expanding and diversifying its production capacity for Monster Silk™.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories to Add Key Personnel

LANSING, Mich., July 8, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Kraig”), the leading developer of advanced spider silk based fibers, today announced plans to add key personnel, in order to support its production growth strategy and expand its ability to service potential clients as Kraig grows.

Kraig is looking to add two talented and experienced individuals to its team, to help with a wide array of responsibilities, ranging from operations to market development.

The fundamental considerations include a balanced mix of qualifications, experience and reputation.

“We’re looking for key individuals, to work as part of a cooperative team to accelerate the Company’s growth in 2013 and beyond,” stated Company CEO and founder, Kim K Thompson. “In addition to improving organizational effectiveness, I welcome the addition of valuable perspective and insight that these key hires may add to our organization. Frankly, as we transition from being a research and development company to the commercialization of new recombinant fibers, we need to add more hands on deck to take on the increased responsibilities. I am thrilled to be adding to our executive team to help guide our product development, sales and marketing, and technological efforts.”

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Ends Quiet Period

LANSING, Mich., July 1, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the “Company”), the leading developer of advanced spider silk based fibers, today announced the end of the quiet period phase related to its recently filed S1 financing registration and a second potential financing that the Company has now terminated.

“We are very happy to be able to announce the end of this quiet period, and we want to thank our shareholders for their patience,” said Company CEO and founder, Kim K Thompson. “Quiet periods during times when certain financings are being prepared are a normal part of the Company’s regulatory compliance obligations. While it is wonderful to receive the underlying finance, the quiet periods themselves are an unwelcome, but necessary burden. Having successfully carried that burden, we are now very happy to set it down.”

During the quiet period, the Company was unable, from its perspective, to effectively disseminate corporate information announcements and public relations announcements. The Company had come to terms with a New York based investment banking firm for a potential financing (in addition to the financing described in the recently filed S1) that would have necessitated a second S1 registration. The Company has determined however that the burden of an additional quiet period, or any further open ended extension of the quiet period, would be too counterproductive. The Company is looking forward to resuming more open communications with the financial markets and shareholders.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Announces Plans to Launch Initial Commercial Production of Monster Silk(TM)

LANSING, Mich., May 7, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the “Company”), the leading developer of advanced spider silk based fibers, today announced plans to launch its initial commercial production of Monster Silk™. The announcement of the Company’s decision to launch commercial production follows the early successes of its of Monster Silk™ pilot production program.

“We have received strong indications of interest from potential customers and potential commercialization partners,” said, CEO and founder, Kim Thompson. “Many of these companies have been very patient with the fact that our laboratory production has been limited and can not satisfy their demand for quantities of material sufficient to run test weaves and end product testing.

“Moving from our pilot production program to commercial production is a very big jump, but it is also a natural progression,” continued Thompson. “We have been laying the groundwork for this expansion over the last twelve months. We are confident in the decision and we are hopeful that we can accomplish the launch during the third and fourth quarters. Our plan is to begin commercial production to meet customer needs, secure future orders and capture market share in the technical textiles market.”

Kraig’s pilot production program will continue to run, in order to supply continuing data and help grow the Company’s production capacity.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .

Kraig Biocraft Laboratories Announces Results of 2013 Meeting of Shareholders

LANSING, Mich., April 17, 2013 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (the “Company”), the leading developer of advanced spider silk based fibers, announced today that all of the Board of Director’s proposals were approved at its meeting of shareholders held yesterday in Lansing, Michigan.

All three amendments to Company’s charter listed on the meeting agenda passed with unanimous attending shareholder approval. The amendments were designed to help management advance the business model in a more streamlined fashion.

“The overwhelming support of the attending shareholders, expressed over nearly four hours of discussions, and the unanimous vote on all of management’s proposals, is a validation of our plans for production and commercialization,” said CEO and founder Kim Thompson. “I am looking forward to communicating further details of our plans and progress to the shareholders in an upcoming shareholder conference call.”

“I would like to thank the shareholders who were able to take time out of their busy schedules to attend the meeting,” continued Thompson. “It was extremely gratifying to meet other shareholders, who share many of the same visions and goals for the Company and the technology.”

A copy of the three amendments to the Company charter which were approved by the shareholders at yesterday’s meeting is available on the Company’s website under the notice of meeting section.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

CONTACT:

Ben Hansel, Hansel Capital, LLC.
(720) 288-8495
ir@KraigLabs.com

This entry was posted on by .